/Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
NEWS

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026

EMA
2026/04/07

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026

Date

Tuesday, 07 April

Friday, 10 April 2026

,

All day

Location

European Medicines Agency, Amsterdam, the Netherlands

Event summary

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

Agenda of the PRAC meeting 7-10 April 2026

Draft

Reference Number:

EMA/PRAC/68437/2026

English (EN) (478.02 KB - PDF)

First published:

07/04/2026

View

Related content

Summary

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026